Market Closed - Nyse Other stock markets | 5-day change | 1st Jan Change | ||
57.68 USD | +0.28% | +3.59% | -26.95% |
05-16 | CVS Health Retail Division Launches Snacks Brand Well Market | MT |
05-14 | Transcript : CVS Health Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 07:20 AM |
September 10, 2020 at 01:30 pm
As part of its comprehensive effort to increase access to COVID-19 testing in order to help slow the spread of the virus, CVS Health announced that children age 12 years and older are eligible for testing at the more than 2,000 test sites located at select CVS Pharmacy drive-thru testing locations, starting September 11. In addition, more than 120 new test sites will open Friday at CVS Pharmacy drive-thru locations across the country. In recent weeks, CVS Health has expanded its network of independent third-party lab partners in an effort to help improve turnaround time for the delivery of test results. As a result, the majority of test results from specimens collected at CVS test sites across the country will generally be available within 2 – 3 days. Self-swab tests are no cost to patients and will be available to individuals meeting Centers for Disease Control and Prevention criteria.1 Patients must register in advance at CVS.com to schedule an appointment. Minors ages 12 and older are now eligible for COVID-19 testing at CVS Pharmacy drive-thru sites. A parent or legal guardian must complete the on-line registration for all minor patients, and patients 12 – 15 years of age must be accompanied by a parent or legal guardian when they come to be tested. Parents or guardians seeking testing for children under the age of 12 should consult with a pediatrician to identify appropriate testing options. When arriving for testing, patients are asked to follow signage or the instructions of the staff onsite. Procedures vary by location and patients may be directed to stay in their cars and proceed to either the pharmacy drive-thru window or a parking space or tent located in the parking lot or, in very limited locations, to enter a CVS store. Patients will be provided with a test kit and given instructions, and a CVS Pharmacy team member will observe the self-swab process. To date, CVS Health has administered more than three million COVID-19 tests since launching its first test site in the parking lot of a CVS Pharmacy location in Shrewsbury, Mass. in March.
Share
© S&P Capital IQ - 2020
Latest news about CVS Health Corporation
CVS Health Retail Division Launches Snacks Brand Well Market | MT | |
Transcript : CVS Health Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 07:20 AM | ||
Argus Research Adjusts Price Target on CVS Health to $80 From $100 | MT | |
Mickey Mouse on Wall Street | ||
ANALYST RECOMMENDATIONS : Walt Disney, Tractor Supply Company, KKR, Occidental Petroleum... | ||
CVS Health Files Prospectus Supplement for Notes Sale | MT | |
FOMO is Back | ||
ANALYST RECOMMENDATIONS : Nvidia, The Home Depot, Lowe's, Rollins... | ||
Wells Fargo Adjusts CVS Health's Price Target to $60 From $76 | MT | |
TD Cowen Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $59 From $99 | MT | |
Ameriprise Downgrades CVS Health to Hold From Buy | MT | |
Aetna will cover fertility treatments for LGBTQ people under court settlement | RE | |
ARC Independent Research Adjusts Price Target on CVS Health to $65 From $80 | MT | |
Wall Street rises thanks to good and bad economic news | ||
North American Morning Briefing : Apple, Amgen -2- | DJ | |
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna... | ||
HSBC Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $62 From $91 | MT | |
Cvs Health Insider Bought Shares Worth $500,294, According to a Recent SEC Filing | MT | |
Deutsche Bank Adjusts Price Target on CVS Health to $64 From $77 | MT | |
Raymond James Adjusts Price Target on CVS Health to $65 From $85 | MT | |
Wolfe Adjusts Price Target on CVS Health to $70 From $88 | MT | |
Morgan Stanley Adjusts Price Target on CVS Health to $65 From $85 | MT | |
Jefferies Adjusts Price Target on CVS Health to $72 From $95 | MT | |
Barclays Adjusts Price Target on CVS Health to $63 From $78 | MT | |
Bernstein Adjusts Price Target on CVS Health to $62 From $93 | MT |
Chart CVS Health Corporation
More charts
Company Profile
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows:- medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursem*nt management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;- retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®);- medical benefits management (25.8%);- other (0.1%).
Sector
Calendar
30/07/2024 - Q2 2024 Earnings Release (Projected)
Related indices
More about the company
Income Statement Evolution
More financial data
Ratings for CVS Health Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
57.68USD
Average target price
71.37USD
Spread / Average Target
+23.74%
Consensus
EPS Revisions
Estimates Revisions
Quarterly earnings - Rate of surprise
Company calendar
1st Jan change | Capi. | |
---|---|---|
CVS HEALTH CORPORATION | -26.95% | 72.21B |
HCA HEALTHCARE, INC. | +19.28% | 84.52B |
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY | +4.65% | 27.74B |
LABORATORY CORPORATION OF AMERICA HOLDINGS | -7.35% | 17.97B |
-0.46% | 17.46B | |
QUEST DIAGNOSTICS INCORPORATED | +4.69% | 15.82B |
REDE D'OR SÃO LUIZ S.A. | +8.14% | 13.55B |
FRESENIUS MEDICAL CARE AG | +6.59% | 13.31B |
TENET HEALTHCARE CORPORATION | +70.00% | 12.5B |
EUROFINS SCIENTIFIC SE | -1.22% | 12.42B |
- Stock Market
- Equities
- CVS Stock
- News CVS Health Corporation
- CVS Health Makes COVID-19 Testing Available for Children 12 Years and Older at its More Than 2,000 Drive-Thru Test Sites